FGF23 and chronic kidney disease: Serum phosphate and FGF23, which are elevated in the advances stages of CKD [78], are able also to induce cardiac hypertrophy [79,80], and they play an important role in myocardial fibrosis through the stimulation of β-catenin and the TGF-β pathway [81].